Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
Parkinson’s disease (PD) is a progressive neurodegenerative disorder, which is characterised by degeneration of distinct neuronal populations, including dopaminergic neurons of the substantia nigra. Here, we use a metabolomics profiling approach to identify changes to lipids in PD observed in sebum, a non-invasively available biofluid. We used liquid chromatographymass spectrometry (LC-MS) to analyse 274 samples […]
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease Read More »